0001078782-14-000332.txt : 20140307 0001078782-14-000332.hdr.sgml : 20140307 20140306202807 ACCESSION NUMBER: 0001078782-14-000332 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20140307 DATE AS OF CHANGE: 20140306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: US-BLH BIO-ENGINEERING INT'L, INC. CENTRAL INDEX KEY: 0001547021 STANDARD INDUSTRIAL CLASSIFICATION: CONSTRUCTION MACHINERY & EQUIP [3531] IRS NUMBER: 452724562 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36235 FILM NUMBER: 14674874 BUSINESS ADDRESS: STREET 1: 699 SERRAMONTE BLVD., STE 212 CITY: DALY CITY STATE: CA ZIP: 94015 BUSINESS PHONE: 650-530-0699 MAIL ADDRESS: STREET 1: 699 SERRAMONTE BLVD., STE 212 CITY: DALY CITY STATE: CA ZIP: 94015 10-Q 1 f10q063013_10q.htm FORM 10-Q QUARTERLY REPORT Form 10-Q Quarterly Report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


Form 10-Q


  X .QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended June 30, 2013


      .TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


Commission file number : 333-181341


US-BLH BIO-ENGINEERING INT’L, INC.

(Exact name of registrant as specified in its charter)


California

 

45-2724562

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)


699 Serramonte Blvd., Ste. 212, Daly City, CA

 

94015

(Address of principal executive offices)

 

(Zip Code)


(650) 530-0699

(Registrant’s telephone number, including area code)


Copies of Communications to:

Harold P. Gewerter, Esq.

Harold P. Gewerter, Esq. Ltd.

5536 S. Ft. Apache #102

Las Vegas, NV 89148

(702) 382-1714

Fax (702) 382-1759

E-mail: harold@gewerterlaw.com


Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  X . No      .


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  X . No      .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Ruble 12b-2 of the Exchange Act.


Large accelerated filer

      .

Accelerated filer

      .

Non-accelerated filer

      . (Do not check if a smaller reporting company)

Smaller reporting company

  X .


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      . No  X .


The number of shares of Common Stock, $0.001 par value, outstanding on February 10, 2014 was 54,521,000  shares.





US-BLH BIO-ENGINEERING INT’L, INC.

QUARTERLY PERIOD ENDED JUNE 30, 2013


Index to Report on Form 10-Q


 

 

 

Page No.

 

 

PART I - FINANCIAL INFORMATION

 

Item 1.

 

Financial Statements

3

 

 

 

 

Item 2.

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

8

 

 

 

 

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

10

 

 

 

 

Item 4T.

 

Controls and Procedures

10

 

 

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

 

Item 1.

 

Legal Proceedings

10

 

 

 

 

Item1A.

 

Risk Factors

11

 

 

 

 

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

11

 

 

 

 

Item 3.

 

Defaults Upon Senior Securities

11

 

 

 

 

Item 4.

 

(Removed and Reserved)

 

 

 

 

 

Item 5.

 

Other Information

11

 

 

 

 

Item 6.

 

Exhibits

11

 

 

 

 

 

 

Signature

12




2



PART I – FINANCIAL INFORMATION


Item 1. Financial Statements.


US-BLH BIO-ENGINEERING INT’L, INC.

(A Development Stage Company)


FINANCIAL STATEMENTS

June 30, 2013


Condensed Balance Sheets as of June 30, 2013 (unaudited) and December 31, 2012

4

Condensed Statements of Operations for the Three and Six Months Ended June 30, 2013 and 2012 and the Period of August 6, 2010 (Inception) to June 30, 2013 (unaudited)

5

Condensed Statements of Cash Flows for the Six Months Ended June 30, 2013 and 2012 and the Period of August 6, 2010 (Inception) to June 30, 2013 (unaudited)

6

Notes to Financial Statements (unaudited)

7




3




US-BLH BIO-ENGINEERING INT'L, INC.

(A Development Stage Company)

Condensed Balance Sheets

 

 

 

 

 

 

 

 

 

June 30,

2013

 

December 31,

2012

 

(unaudited)

 

ASSETS

Current assets

 

 

 

 

 

 

Cash

$

-

 

$

-

Total current assets

 

-

 

 

-

 

 

 

 

 

 

 

Total assets

$

-

 

$

-

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable

$

1,500

 

$

3,351

 

Related party loans

 

6,185

 

 

1,706

Total current liabilities

 

7,685

 

 

5,057

 

 

 

 

 

 

 

Stockholders' (deficit)

 

 

 

 

 

 

Common stock, no par value; 250,000,000 shares authorized; 54,521,000 issued and outstanding

 

81,781

 

 

81,781

 

Deficit accumulated during development stage

 

(89,466)

 

 

(86,838)

Total stockholders’ (deficit)

 

(7,685)

 

 

(5,057)

 

 

 

 

 

 

 

Total liabilities and stockholders' (deficit)

$

-

 

$

-

 

 

 

 

 

 

 

See accompanying notes to unaudited financial statements.




4




US-BLH BIO-ENGINEERING INT'L, INC.

(A Development Stage Company)

Condensed Statements of Operations (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

Period from August 6, 2010 (Inception) to June 30, 2013

 

 

2013

 

2012

 

2013

 

2012

 

Revenue

$

-

 

$

-

 

$

-

 

$

-

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

1,403

 

 

1,743

 

 

2,628

 

 

15,865

 

 

68,434

Total operating expenses

 

1,403

 

 

1,743

 

 

2,628

 

 

15,865

 

 

68,434

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(1,403)

 

 

(1,743)

 

 

(2,628)

 

 

(15,865)

 

 

(68,434)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

-

 

 

-

 

 

-

 

 

100

Total other expense

 

-

 

 

-

 

 

-

 

 

-

 

 

(100)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before taxes

 

(1,403)

 

 

(1,743)

 

 

(2,628)

 

 

(15,865)

 

 

(68,534)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax

 

-

 

 

-

 

 

-

 

 

-

 

 

(1,700)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(1,403)

 

$

(1,743)

 

$

(2,628)

 

$

(15,865)

 

$

(70,234)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per common share

$

(0.00)

 

$

(0.00)

 

$

(0.00)

 

$

(0.00)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

54,521,000

 

 

54,521,000

 

 

54,521,000

 

 

54,697,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to unaudited financial statements.




5




US-BLH BIO-ENGINEERING INT'L, INC.

(A Development Stage Company)

Condensed Statements of Cash Flows (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30,

 

Period from August 6, 2010

(Inception) to

June 30, 2013

 

 

 

2013

 

2012

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

 

Net loss

$

(2,628)

 

$

(15,865)

 

$

(70,234)

 

Changes in operating liabilities:

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

(1,851)

 

 

400

 

 

1,500

Net cash used in operating activities

 

(4,479)

 

 

(15,465)

 

 

(68,734)

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

-

 

 

-

 

 

-

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

 

 

 

Proceeds from related party loans

 

4,479

 

 

1,343

 

 

6,185

 

 

Dividends paid

 

-

 

 

-

 

 

(19,232)

 

 

Proceeds from sale of stock

 

-

 

 

-

 

 

82,500

 

 

Cancellation of common shares

 

-

 

 

(719)

 

 

(719)

Net cash provided by financing activities

 

4,479

 

 

624

 

 

68,734

 

 

 

 

 

 

 

 

 

 

 

 

Net change in cash

 

-

 

 

(14,841)

 

 

-

 

Cash at beginning of period

 

-

 

 

18,346

 

 

-

 

Cash at end of period

$

-

 

$

3,505

 

$

-

 

 

 

 

 

 

 

 

 

 

 

Supplemental cash flow information

 

 

 

 

 

 

 

 

 

Cash paid for interest

$

-

 

$

-

 

 

 

 

Cash paid for income taxes

$

-

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to unaudited financial statements.




6



US-BLH BIO-ENGINEERING INT’L, INC.

(A Development Stage Company)

Notes to Financial Statements (unaudited)

June 30, 2013


NOTE 1 – CONDENSED FINANCIAL STATEMENTS


The accompanying financial statements have been prepared by the Company without audit.  In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows June 30, 2013 and for all periods presented herein, have been made.


Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2012 financial statements.  The results of operations for the periods ended June 30, 2013 are not necessarily indicative of the operating results for the full year.


NOTE 2 – GOING CONCERN


The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.


In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.


The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern


NOTE 3 – RELATED PARTY


During the period ended June 30, 2013, the Company advanced additional $4,479 loan from related parties. The balance as of June 30, 2013 and December 31, 2012 was $6,185 and $1,706, respectively.  The advance from related parties is due on demand with no interest incurred.


NOTE 4 – SUBSEQUENT EVENTS


The Company has evaluated subsequent events through the date of this filing and determined there are no events to disclose.



7



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations


This Quarterly Report on Form 10-Q contains forward-looking statements and involves risks and uncertainties that could materially affect expected results of operations, liquidity, cash flows, and business prospects. These statements include, among other things, statements regarding:


·

our ability to diversify our operations;

·

inability to raise additional financing for working capital;


·

the fact that our accounting policies and methods are fundamental to how we report our financial condition and results of operations, and they may require our management to make estimates about matters that are inherently uncertain;

·

our ability to attract key personnel;


·

our ability to operate profitably;

·

our ability to generate sufficient funds to operate the US-BLH BIO-ENGINEERING INT’L, INC. operations, upon completion of our acquisition;


·

deterioration in general or regional economic conditions;

·

adverse state or federal legislation or regulation that increases the costs of compliance, or adverse findings by a regulator with respect to existing operations;


·

changes in U.S. GAAP or in the legal, regulatory and legislative environments in the markets in which we operate;

·

the inability of management to effectively implement our strategies and business plan;


·

inability to achieve future sales levels or other operating results;

·

the unavailability of funds for capital expenditures;


·

other risks and uncertainties detailed in this report;


as well as other statements regarding our future operations, financial condition and prospects, and business strategies. These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this Quarterly Report on Form 10-Q, and in particular, the risks discussed under the heading “Risk Factors” in Part II, Item 1A and those discussed in other documents we file with the Securities and Exchange Commission. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.


References in the following discussion and throughout this quarterly report to “we”, “our”, “us”, “US-BLH”, “the Company”, and similar terms refer to US-BLH BIO-ENGINEERING INT’L, INC. unless otherwise expressly stated or the context otherwise requires.


OVERVIEW AND OUTLOOK


Background


The Company is a medicinal production equipment exporter. We will sell production equipment to buyers on an international basis. We will be working closely with Longshengbeiyao Bio-Engineering Co., Ltd., in Harbin, PRC, and will work towards modernizing production technology to make sure that individuals and producers the world over may economically produce certain medical products. Much of our early success will depend on our relationship with. Longshengbeiyao Bio-Engineering Co., Ltd., which currently occupies 50,000 square meters of land in China, has 30,000,000 RMB in registered capital, and total assets of 100,000,000 per year. Its total plant square footage is currently 16,000 square meters. According to research, there is a market for antihypertensive drugs in China worth 2 billion USD. The rate of hypertension in China has reached the 30% mark among 35 – 74 year-olds, giving us a large market for antihypertensive drugs. The main product of said company is antihypertensive drugs based on tortoise shell extracts.


Going Concern


The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. As of June 30, 2013 the Company had an accumulated deficit of $89,466. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.



8



The Company is currently contemplating an offering of its equity or debt securities to finance continuing operations. There are no agreements or arrangements currently in place or under negotiation to obtain such financing, and there are no assurances that the Company will be successful and without sufficient financing it would be unlikely for the Company to continue as a going concern.


The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations.


RESULTS OF OPERATIONS


During the three and six months ended June 30, 2013, we generated revenue of $0. During the three and six months ended June 30, 2012, we generated revenue of $0.


Operating expenses during the three and six months ended June 30, 2013 were $1,403 and $2,628, respectively, all of which consisted of general and administrative expenses such as accounting, professional and miscellaneous office expenditures. In comparison, operating expenses for the period ended June 30, 2012 were $1,743 and $15,865 all of which consisted of general and administrative expenses such as accounting, professional and miscellaneous office expenditures.


We have not been profitable from our inception in 2010 through June 30, 2013, and our accumulated deficit amounts to $89,466. There is significant uncertainty projecting future profitability due to our history of losses and lack of revenues. In our current state we have no recurring or guaranteed source of revenues and cannot predict when, if ever, we will become profitable. There is significant uncertainty projecting future profitability due to our minimal operating history and lack of guaranteed ongoing revenue streams.


Liquidity and Capital Resources


As of June 30, 2013, we had $0 in cash and did not have any other cash equivalents. The following table provides detailed information about our net cash flow for all financial statement periods presented in this Quarterly Report. To date, we have financed our operations through the issuance of stock and borrowings.


The following table sets forth a summary of our cash flows for the three months ended June 30, 2013 and the period ending June 30, 2012:


 

 

Six Months

Ended

June 30, 2013

 

Six Months

Ended

June 30, 2012

Net cash used in operating activities

 

$

(4,479)

 

$

(15,465)

Net cash used in investing activities

 

 

-

 

 

-

Net cash provided by financing activities

 

 

4,479

 

 

624

Net increase (decrease) in Cash

 

 

-

 

 

(14,841)

Cash, beginning

 

 

-

 

 

18,346

Cash, ending

 

$

-

 

$

3,505


Since inception, we have financed our cash flow requirements through issuance of common stock. As we expand our activities, we may, and most likely will, continue to experience net negative cash flows from operations, pending receipt of listings or some form of advertising revenues.  Additionally we anticipate obtaining additional financing to fund operations through additional common stock offerings, to the extent available, or to obtain additional financing to the extent necessary to augment our working capital.


We anticipate that we will incur operating losses in the next twelve months. Our lack of operating history makes predictions of future operating results difficult to ascertain. Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development, particularly companies in new and rapidly evolving markets. Such risks for us include, but are not limited to, an evolving and unpredictable business model and the management of growth. To address these risks, we must, among other things, obtain a customer base, implement and successfully execute our business and marketing strategy, continually develop and upgrade our website, provide national and regional industry participants with an effective, efficient and accessible website on which to promote their products and services through the Internet, respond to competitive developments, and attract, retain and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial condition and results of operations.


Operating activities


Net cash used in operating activities was $4,479 for the period ended June 30, 2013, as compared to $15,465 used in operating activities for the period ended June 30, 2012. The decrease in net cash used in operating activities was primarily due to a decrease in professional fees.



9



Investing activities


Net cash used in investing activities was $0 for the period ended June 30, 2013, as compared to $0 used in investing activities for the same period in 2012.


Financing activities


Net cash provided by financing activities for the period ended June 30, 2013 was $4,479 as compared to $624 for the same period of 2012. The decrease of net cash provided by financing activities was mainly attributable to an offering of common stock for cash that did not result in as much cash as the precious period.


We believe that cash flow from operations will not meet our present and near-term cash needs and thus we will require additional cash resources, including the sale of equity or debt securities, to meet our planned capital expenditures and working capital requirements for the next 12 months. We will require additional cash resources due to changed business conditions, implementation of our strategy to expand our sales and marketing initiatives, increase brand awareness, or acquisitions we may decide to pursue. If our own financial resources and then current cash-flows from operations are insufficient to satisfy our capital requirements, we may seek to sell additional equity or debt securities or obtain additional credit facilities. The sale of additional equity securities will result in dilution to our stockholders. The incurrence of indebtedness will result in increased debt service obligations and could require us to agree to operating and financial covenants that could restrict our operations or modify our plans to grow the business. Financing may not be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable to us, or at all, will limit our ability to expand our business operations and could harm our overall business prospects.


Off-Balance Sheet Arrangements


We did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.


Item 3. Quantitative and Qualitative Disclosure About Market Risk


This item is not applicable as we are currently considered a smaller reporting company.


Item 4T. Controls and Procedures


Evaluation of Disclosure Controls and Procedures


Our Principal Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the period covered by this Report. Based on that evaluation, it was concluded that our disclosure controls and procedures are not designed at a reasonable assurance level and are not effective to provide reasonable assurance that information we are required to disclose in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.


Changes in Internal Control Over Financial Reporting


There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


Limitations on Effectiveness of Controls and Procedures


In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.


PART II—OTHER INFORMATION


Item 1. Legal Proceedings.


We are not a party to any material legal proceedings.



10



Item 1A. Risk Factors


The risk factors listed in our 2012 Form 10-K on pages 5 to 10, filed with the Securities Exchange Commission on February 10, 2014, are hereby incorporated by reference.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.


Stock Issuances


None.


Issuer Purchases of Equity Securities


We did not repurchase any of our equity securities from the time of our inception through the period ended June 30, 2013.


Item 3. Defaults Upon Senior Securities.


None.


Item 5. Other Information.


None.


Item 6. Exhibits.


Exhibit No.

 

Description

 

 

 

31.1

 

Certification of Principal Executive Officer & Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1

 

Certifications of Principal Executive Officer & Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS*

 

XBRL Instance Document

 

 

 

101.SCH*

 

XBRL Taxonomy Extension Schema

 

 

 

101.CAL*

 

XBRL Taxonomy Extension Calculation Linkbase

 

 

 

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase

 

 

 

101.LAB*

 

XBRL Taxonomy Extension Label Linkbase

 

 

 

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase

*XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.




11



SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 

 

US-BLH BIO-ENGINEERING INT’L, INC.

 

 

 

 

 

 

 

 

Date: March 5, 2014

 

By:

/s/ Guozhi Wang

 

 

 

GUOZHI WANG

 

 

 

Chief Executive Officer

 

 

 

(Principal Executive Officer and duly authorized signatory)




12


EX-31.1 2 f10q063013_ex31z1.htm EXHIBIT 31.1 SECTION 302 CERTIFICATION Exhibit 31.1 Section 302 Certification

Exhibit 31.1


CERTIFICATION


I, Guozhi Wang, certify that:


1.

I have reviewed this Annual Report on Form 10-Q of US-BLH Bio-engineering Int’l, Inc.;


2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report;


4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:  March 5, 2014


/s/ Guozhi Wang

Guozhi Wang

Chief Executive Officer

(Principal Executive Officer)




EX-31.2 3 f10q063013_ex31z2.htm EXHIBIT 31.2 SECTION 302 CERTIFICATION Exhibit 31.2 Section 302 Certification

Exhibit 31.2


CERTIFICATION


I, Bing Cao, certify that:


1.

I have reviewed this Annual Report on Form 10-Q of US-BLH Bio-engineering Int’l, Inc.;


2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report;


4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d) - 15(f)) for the registrant and have:


a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: March 5, 2014


/s/ Bing Cao

Bing Cao

Chief Financial Officer

(Principal Financial Officer)




EX-32.1 4 f10q063013_ex32z1.htm EXHIBIT 32.1 SECTION 906 CERTIFICATION Exhibit 32.1 Section 906 Certification

Exhibit 32.1


CERTIFICATION PURSUANT TO 18 U.S.C. 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge, the Quarterly Report on Form 10-Q for the period ended March 31, 2013 of US-BLH Bio-engineering Int’l, Inc. (the “Company”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such periodic report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in such report.


Very truly yours,


/s/ Guozhi Wang

Guozhi Wang

Chief Executive Officer

 

/s/ Bing Cao

Bing Cao

Chief Financial Officer

 

Dated: March 5, 2014


A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to US-BLH Bio-engineering Int’l, Inc. and will be furnished to the Securities and Exchange Commission or its staff upon request.




EX-101.INS 5 usbh-20130630.xml XBRL INSTANCE DOCUMENT 0001547021 2011-12-31 0001547021 2012-04-01 2012-06-30 0001547021 2012-01-01 2012-06-30 0001547021 2012-06-30 0001547021 2012-12-31 0001547021 2013-04-01 2013-06-30 0001547021 2013-01-01 2013-06-30 0001547021 2013-06-30 0001547021 2010-08-06 2013-06-30 0001547021 2014-02-10 xbrli:shares iso4217:USD iso4217:USDxbrli:shares US-BLH BIO-ENGINEERING INT'L, INC. 0001547021 usbh --12-31 Smaller Reporting Company 54521000 10-Q 2013-06-30 false 2013 Q2 18346 3505 3351 1500 1706 6185 5057 7685 81781 81781 86838 89466 -5057 -7685 250000000 250000000 54521000 54521000 54521000 54521000 1743 15865 1403 2628 68434 1743 15865 1403 2628 68434 -1743 -15865 -1403 -2628 -68434 100 -100 1700 -1743 -15865 -1403 -2628 -70234 -0.00 -0.00 -0.00 -0.00 54521000 54697599 54521000 54521000 400 -1851 1500 -15465 -4479 -68734 1343 4479 6185 19232 82500 719 719 624 4479 68734 -14841 <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2"><b>NOTE 1 &#8211; CONDENSED FINANCIAL STATEMENTS</b></font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The accompanying financial statements have been prepared by the Company without audit. &#160;In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows June 30, 2013 and for all periods presented herein, have been made.</font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. &#160;It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company&#8217;s December 31, 2012 financial statements. &#160;The results of operations for the periods ended June 30, 2013 are not necessarily indicative of the operating results for the full year.</font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2"><b>NOTE 2 &#8211; GOING CONCERN</b></font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The Company&#8217;s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.</font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management&#8217;s plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.</font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern</font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2"><b>NOTE 3 &#8211; RELATED PARTY</b></font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">During the period ended June 30, 2013, the Company advanced additional $4,479 loan from related parties. The balance as of June 30, 2013 and December 31, 2012 was $6,185 and $1,706, respectively. &#160;The advance from related parties is due on demand with no interest incurred.</font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2"><b>NOTE 4 &#8211; SUBSEQUENT EVENTS</b></font></p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p align="justify" style="font: 13px/normal 'times new roman'; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The Company has evaluated subsequent events through the date of this filing and determined there are no events to disclose.</font></p> -1743 -15865 -1403 -2628 -68534 EX-101.CAL 6 usbh-20130630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.LAB 7 usbh-20130630_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT EX-101.PRE 8 usbh-20130630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 9 usbh-20130630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - CONDENSED FINANCIAL STATEMENTS link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - RELATED PARTY link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - RELATED PARTY (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!4F&Q9AP$``%D)```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,EEU/PC`4AN]-_`]+;\W6 M@8IH&%SX<:DDX@^HZQEKV-JF+0C_WK/R$4,FA$AB;]:L[7G?I[WH>P:C95U% M"S!6*)F13I*2"&2NN)#3C'Q,7N(^B:QCDK-*2R[QQB'!2K_'ED+;*\0@M-6A M6?G=8%/WAE=C!(=HS(Q[935BT&5%OY29?2HU2PZ+M%"JHA`Y<)7/:[R!Q&H# MC-L2P-55XL>D9D)NN0_X^\V6^J%S9I#F?%[X1(YN(!S7@7#^;3KD6/.9?,`']W!B/^ M[``_M0]Q8`".C=(66P$#I]_"-NN;ZEBC$!@G8)?V;:FY<\0VXG3#O=B&IE'A MP%N\J6^,AM\```#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P"```+``@" M7W)E;',O+G)E;',@H@0"**```@`````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````C)+/3L,P#,;O M2+Q#Y/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I M5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NH MLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&74"T\U<%J"`=[ M!ZH^^CSYLK$SO+=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'! MQ0]47P```/__`P!02P,$%``&``@````A`)(9$>%#`0``M`<``!H`"`%X;"]? M2U+ M3EZ.CW<;$J`1,A>-DL!)#TCVZ>W-[@D:8>PCK.H.`ZLBD9/*F.Z>4LPJ:`6& MJ@-I;PJE6V%LJ4O:B>PD2J!Q%"54_]8@Z9EF<,@YT8?<^A_[SCK_KZV*HL[@ M066O+4ASP8*^*WW""L!84:%+,)R,+:3#S2:TQ(1>AF$+GS18"0WYL]$V;)R( MSMHN&J\P8PX3R-CZCF;A@EG[3&9T_AMF[8)AL4\:-'UCQWX_5_HHP M8A<,\YG%%3#,!9/,#).X8)C7:(Q=>C!-R5#2X70FLIHYD94S$;O_9UVW+'+A M+&>F6;I@MC/#;']@Z-E?FWX"``#__P,`4$L#!!0`!@`(````(0!9D&1>%@(` M`&\$```/````>&PO=V]R:V)O;VLN>&ULC%1=;]HP%'V?M/\0^7U-"+1K$5#Q MD79(76`D4.W)\I(+L>K8D6T*_/O=!,$,VZ0^.=?7Y]QSCV_<>]R7PGL';;B2 M?=*Z"8@',E,YEYL^6:9/7^Z)9RR3.1-*0I\=/O9W2;[^4>O.00)H^ M*:RMNKYOL@)*9FY4!1(S:Z5+9C'4&]]4&EAN"@!;"C\,@CN_9%R2(T-7?X1# MK=<\@XG*MB5(>R31()A%^:;@E2&#WIH+6!T[\EA5Q:Q$W7M!/,&,C7)N(>^3 M6PS5#BXV]+8:;;G`[$,[:!-_<&YRKKT= M^0.J0V__RF6N=O51M/9PCMHH8->D7GEN"\P'07#>^P9\4]C3)M+[#G_C(-9I M5D\V[9T>YJU:N,LR5C(':2"G M(R:8S(`F-9]/XF8YG\3A:Q"[*M?/K=?%%](*5)G0^7*0_791KW_TU*EF. MDNC'$O71:'6MTK7LX1IY48].P#(N:`I[NV7"G8$63O+9,@SJ^6RZQ:',F,CP M;ZF7>MR.R=-;,?@-``#__P,`4$L#!!0`!@`(````(0!K+72ZF`0``,$3```8 M````>&PO=V]R:W-H965T&ULE)A;CZLV$,??*_4[(-XW7!+( M14F.E@#MD4ZEJNHY?2;$2=`"CH!L=K]]9S`W&X+9EUP\/P_^CX=A\/;;1Q(K M[R3+(YKN5&.FJPI)0WJ*TLM._?FO_[)2E;P(TE,0TY3LU$^2J]_VO_^V?=#L M+;\24BC@('L0C"VG?YI^<^B<*,YO1_45V/C&[:J[;=E@'Y%Y)%W?BOYE3[^R*+3CR@E M$&W8)]R!(Z5OB'X_X1!,UGJS_7('_LZ4$SD'][CXAS[^)-'E6L!V6Z`(A6U. MGR[)0X@HN)F9%GH*:0P+@$\EB3`U("+!1_G]B$[%=:?.[9FUU.<&X,J1Y(4? MH4M5">]Y09/_&&14KI@3LW(",RHG!@Q-G&Q7D^&[GFS/%J:U7$U8@L;DE-%Q M@R+8;S/Z4"#E8,'Y+<`$-C;@N0X+$]$$ZEF<($#HY!6][-2EJD`(83_""G$&D#6/'&H$HX]NW7J@=6OP4[R:J*?X;``^FY58>C-'`]&-T-PU#VGNVD;2-%WB$ M!Z$U<2IF+`9RQ)4CGASQ&P3[+$-O'SE\#+`3FIS^ M!NN;NH\[NW7,GO<5,QH#YF8$<>5>/#GB-PC&X.5Y$+`YFAX$UDIQ01!:-@<; M=KA?GEB7`1X8J`,\,%0(>,)>6<_*OH&]T73]K)/B](M-7^EQIX[L\$&. MN'+$DR-^A=1[L7QZ*\!JOQ`%I/ER8`L/;<=@S*I\Y@\]"P1@(`LX#T-9P`&# M6<`12]U\F@78&G6R`%_RYE`BQY^(^'8LQJ'M+JJ2P!@6!Z%>'"H'@T9WS.B- M&?W*".('&DZ^!&)S]'7=K*7B[@*AZW+@I**M`M;",J$"]>3+&7>"'T]@[/72 M6@N/)SPYP?6,Q82=C+!W_X1D%W(@<9PK(;WCJ<<<,KD9;4YD7DU\X17&'6,# M;^K]<=?8P.LXC&O-!#A`N047\E>07:(T5V)RADOILR5D3<:.8-B?@M[*DX@C M+>#HI/QYA:,R`F<`^@S@,Z5%_0&PO["OAKJ6 M9DZT=((X\B;ZBY?JWT]_^YMQFKT$WN]T)'3_2;.^T_)./RXE^K6NYR_-X"1)_^,\FSK[[ M7?[GW1_?O>O^^]OO_OFCM_S73]_L?O;3MWIG.NX4=J;C51S5YDP#SI!/-\]1 M_#6RZ;.S9;8:RP:#]87![L7"V;^R0=T49OE0/ MH`[7;A1]=-TC_7M@T^L2>7+A`>UM%&.H0M%G7:_UVMAHY\$/O52[][YJ/\:A M$Y&`_.#)6'7XL5](\#;AF944YOT@J"98O1YF6'1F.L9<+_.2R,:!5KQ_>%EC M:A-A6DJ\._GW&K[]F#@OALD&>+D&:1SX2V+Q.&<3JF)`FU_?V?,[9I=C)LOB M`*AMSP=O`'HW&\W;9SH?C=H&-6V\6@;]T*=7RZ`V_INW%M.BI%EMD:SPM,RG M94KW_6`T&@V-Z^%P.+)ZAF6Q("^*C/:CI;?U:.726IAV&?3!8-0;CJY-$.E: M0V;JH@QZ(##H]X=]8V1:^)_5MK=GT'9,^[IJ53D&BE3E&"A2EFX1)TM<7:BVS+M82^7GIN/`6V58 MN27^XQ/]S>(U_EW$68:]^.EXZ3N/<>0$>-LI6Y1_C[3$U0IR4%4'BV;=UL#J#JR^>9TO;%HR'7I+?Q/N>E?9WJL?PDBQ;7:< MBV%4&2E6OO563X=4*.23;,&D9DI+-D!.E"DAV:(-'^MM3UD?N19R/G(-)'WD M6LCZB*ZSKW.5D5S&&UPH>RVP;0^[W7SG1];.<4".^)Z,V4^":[,;S\8F>R+: MV.947U%?=OK&S*07FT7N\;2AQ:Z?#0WV>-G00M9',6]*=07P:HE/Y7D/DU?Q M%KY^C$91ZC%RN%X0?*9:_H]5-7Q@YV(ZWJZXRZVX7DW[DW3EE=YB>[!XFP\5 M^0$X'FID'FRD.>MU\'*_"1=>8K.+V,P$.TO;D/71C(UQ]?&'P'^,0H_MO>@Y MS`])G'ENQBZRLVW30WQZ!_C@VJ\TGW/L6P?L(TX7L8^U_5X1$1>E]I%ZG:!(:DC`)_4Q/FTRP`JN9``15##`:J-D@/14P0`SXY(!$K1F`#I'LN*< M?FAPU0PY4)N$_;BF8?$,O#Y5?V#_BI2V4W[/"S-5;)'H=9AP<(7"6 MR4,E5E6)X61'3ZM#@(,C(;`QZK8SY!F':KZR@'!%%QSJB*`,'(M(>UG)U5S8 MK`DVGJ$0.7R_[56VU7C1JIQ:-$$K+)YOGK*5X[0@JVEN*4T M_9[&*?=.M:/%:M(RVZ."RX?"I6 MK2--V3DLN'PJ5JTC&')8%HRQUI' M,?9]R=B_KJABQIN2&9^CU-KA'1F)T+,L`F2,DCWWB9+ MG"K_Q"YE2@;FGF[DJC#$$I'_G+6\ZZR8?][COJTRB+2>Y(H!71>5(?[73<:% MD5U-K><6^!V:%,B#G^%6S;(3BSQ`2X;'0XR]E`KB5461Q/B[DT346X2N^RI' M#WA4[TQA]K_)?>RMD$V4/UX42OW_^%W02-9"J^ M]8/_)_VK4G]U>]:WY[/;6'G7-[OR_"!D]X.8&SUXYXP$R[$$WV)LRK)LTP&-F MDL+9@OSG^MQ$YPYR^NR64M#&O9:E$YVT>@#/]'\```#__P,`4$L#!!0`!@`( M````(0#^YU40!PH``/P;```4````>&PO;GK8?)U?XW+68L5R&/M!+GK:4PK>\O_OJ7,V,LPUEESEL+:Y-O M#P]-L!`Q-PB_JNO8?Q_L>;']C'X>W^8'0]'`T& M]\/1-1N.)GLW;?SI'=2/Y()[\%;*(W@I%,_L'V)9W[?7Z72ZIR+).FZMW._N>M)^Y$*C7A<[/=ET!PZ%!\%?'&O7LS'IG& MA:4V5<=>(1M,78N]36BN'\\UW"S@\U%=9D\#/!@/^0P(:]?1CW MV9MW]?U]$2"SNBZSFL)RB'!C(*)^M,=-`U1[7[]\_5+?.-$6``MV"O-[MER4 MGXPDG\I(6BD:NEP&CI0,2_B23Z-&4.Y%!'2&6$[!0Y'FJB%B79>([=G3::2.9Z1\S'M\\LPN=RE]% M^!T[/6F?'G7=JC0F@]Y$HGI'!G@=&`]`NIDW- M;J?FRT;YS17G.,U>>7@[-N^0XF!_826HR+S;!M:Q11"=)7H&WE+`MP2R[K0! M*.#K[62^/1CLK50LU%'$4Z`'+.7B\4(T&S&K0W[]OGR[C^6KMNZ(]E7M@4V4- M1.:6`+SB&6V)::;[M5`P-G+@XV$LE:O(5CXV9'G`HKLAW^R0>*.-8;-4QRS? M"S_6(W4+A*:%3O7%H;("=6XJT"4)9OEST_#@JLYV@@D^PH,%1[[ M=I,_`U(KHV*Z=FS'+72@HIE4CX`$X>[U9V:>UW:>N4MU($28(S9]N;CUX1;T M!3B1<-EHK]?%&1X)(A3'ZG6W]*BG`%DZOL6F*H8:V"-,.A\FJ:;[0S9=LM?8 MYPZZB)'G2413#WB:6S9%-ZX4>1C*(,O1S6W;"O.W;QIG21*YVD*M2A%&W+YU M8NG1)O(FPQ9L].F_\?+*+I?A&U.[=SOJ#T;C09]=#4>7H][P\H:-)Y>3P:?! M:#)NR"W[O%4=K(Q79*@OJD6OS6Y5M&1]-/O(_PP)OYV61[>3`>NR/W_[G?UO M2DT6@EH0W]Q33/)8PZ6F*`>&+<`=B)M0#`,FFB(/"Q!CJ>J31"^4872D(G;` MOGX9*D;K.@'3H\[#N)@KT`_U`FV&Z8+Q\*?,6/H,"GE:R&"!D`11%N(4&:YH ML(U8*J@-=0FY.O".*1$(8WBZ9!9]&F@<*5'4G>:[0ARF01;H,R MJY(!98"R$C^&H52*BL:XV!.IQ1Q> MQ68N6%NEK6!A&623VPTS M"R1RQ;"YK\(0COTBH;*`L^2O!T7-A^\!G(&>C,0]LY94T$('I M'2)2WR534LQHU"1N@C6!1@O&)#%0V=T&VN`S81H,HY^PZG=2ZF;@9JRM^\"K MYL@7\G%WIHJX^LM0`M9O:I,L1")" MVX&4T'`GZ`2.$YQBXZ]'F]_(D2&BD&*Z?\$![36+GR123J$I0PE`5XU^!(E( MV0@G&'P7HI2!CN"`PA%(6A=C8.-36@4;/<-I.AH)4'2@XIW(&V M:N7Q0K[KC5=UTL'"R+F2`!&]7KH>/1_Y:]B*\60$[QE&HQ75S56PBI',BQ/B M9PHR'$_ONP#>(1@H%%-4SZ*-/6`_Z"=`.*W4;/A`$?[SOA`'<1@O'7A512&& MTSSG%^0!#H=S$42X@0HUZ(T2SK<:E#H.:)"!;"&MR7_-L%("_A^0GB7`.MU2 MR$*45GKY8HB206HY@#AEX!,3I'(*!.:J M/_+QB&GRHR"LFB6Y(RF)5K>03KWLW`]NT.;VV=WE_>3'QF(^W*";!<+PSJT, MS5+TS/%"!WOL"M1.X7W_1@8'Y^48OZ,TJO%ZGO/PD4`*AEUE])N3]LF'O[EG M1?^&4)W(\%KIPS#-'V3!P@ABK>`C\LWFX@E;W[QO=[\Y=9%^TVU_Z+QWG6"$^2Q=2"_U!?C`ZL[O[QP\?QX/,# M1A`V^.>F062<30W2GVK`@*#[8EA.7%A>E$O96M`;E4M!3Z?N#=>L;G3)0GR1 MZFSNTPWEV55-$"_&8SP7`_-DH[X`+"A&Z:)N;#?<:A-C; MOD#"16PBGBE/M[]67GJD;`Q)WFHL8DO>\/.=PP+.[5]F@%ZZ-4&V.HR#$B+=,E:)=Y?CWK\>K M&XR,I6U)&]7R'+]Q@^^*SY]F&Z6?3#0FAS7UG89(8;57%(3J(ZW\$^E MM*06IGI%3*\RVY)>!4S$H!&;BR(\VK'-]'V2+%I)CU]?DC^,8:+ M%N4WT7(H-FR3VX"E4L].^E2ZGR"8G$4_]AOP0Z.25W3=V)]J\Y6+56UAMQ-( MR.65E6\/W#`H*-@$<>*#LRC*!XKY?%JB'B[EW07THJ`ULY4LQC6?D!1$L7A'<;TW(8"W9X0:?9S1!4$N&!T8)WO[/HVYETR/),E0L1A3#!!A MG8\CNJ`=/]`=7?'O5*]$:U##*^BI,+B&!+6_[/S$JJX_N$MEX9+JAS6\ MDSBCTED# M``#Y"P``&````'AL+W=O/9%JE3EM%ZG]B_?SW9%;85K;RF'93O%@>4Y3H"](>2`Q_<6[Q@AR\MS;[1FD"T89WD M"NP8>Y+2QTS^!8/=L]$/W0K\:*V,Y/BY%#_9X2NA^T+`Q,$MQ,'^_U@N!X'.[,X1&'T,8*KIM-%YQX+O%ZU[&!! MR@$P;[!,8+0$Y\OA@#A([9T4=T-@IAS6\&4]BU;N"X0][26;"Q)=L;V@F!\E M+F`=V2`VT]FD&!;%MDYL\=&VP]\H23"0A+IB.Z;0T.`[T]&D.+'!^X2VT#^\ M49(AFN_IDNVH1(,#F^EP4JS#^4C_\D9)1N%&)1H<[);I<%)LP,T,."49A1N5 M:'#1-7!2K&><[QMP2C*$,S-N3*&AS:]!DV(C;H&!IB1AMXM1Z)G9-GSM^^$I M)30H>3I.KAY2;$`9T=@HB8**4&R\W@Y?H[EWJCT:U.(:*"DVH$ZVJFPHB8*: M1V=0P]>A%_ZGEB$XL::'JE,;N74R5EB]9BRY1B5:S)!Q#LCC,8!]\\%YH&KY ML++Y9M'MG!-;A2]&\_B42MT\MB,"'5$6YT&R240?HOH!HBKI&J)9?.4A#$F@ M$&_B11`9*;`U%%$\F*8.>=7!@,Y/AL#8B)M>T\-=R#]=,)*!LD9?'S\Y2M\@ M@;&"&^C;I&:8B6>GU[A&Q5`U;ZH]:?">?,?MGM;<*DD.:^TYF??T/``#__P,`4$L#!!0`!@`( M````(0"I9#*[H@,``%P,```8````>&PO=V]R:W-H965T&UL ME)==;Z,X%(;O5YK_@'Q?P`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`@EK<^LO$V1GK"ZK8[ MV]NTG:IOP(9VW#F;<=,R M0WO8V3C;-YA^";8_?1Y/+C`VI_?P-,'.EMRTS+Q)3HSCI(]LDM<"PP7TB&U. M']K3S9DC?F@NZJO2Q-Y@PPQC1^Z^?8.YYD\?V=/]F0/>\N=N73Q^"$3NWGV# MN>8/UOD!?YJVFR]RMR\,>)JQ\M<';^L[9GK$U-?,;F80*:DXT"TM"NEE_*1G M,0RMTWW;#9?MU-?]`&-:30[T*Q$'5DFOH'NX-?07\$@09M`S%XK7S9BSXPH& MM.;C$:9X"F-#Z`.\YUQ=+O10TOTO6/\&``#__P,`4$L#!!0`!@`(````(0#[ M8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW M('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PK MT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7'; MJUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:; MN.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D M#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=V MJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^ M\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!& M1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H M`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1Z!Y% M'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$Z MGBD".S1P1%H$B)Z9B1)?7B? M-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV9 M6\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86 MXX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6 MP'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[PX7988*0S MI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0 MH+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ M25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CL MJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#> M$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<GC#251E_XN!R?<\_U]65]_:0;\BBM4Z;-:1+%E,A6 MF$*U54Y__;R[N*+$>=X6O#&MS.FS=/1Z\_'#^F#L@ZNE]`086I?3VOLN8\R) M6FKN(M/)%KZ4QFKNX=56S'56\J)?I!N6QO$ETURU-#!D=@J'*4LEY*T1>RU; M'TBL;+B'_%VM.O?"IL44.LWMP[Z[$$9W0+%3C?+//2DE6F3W56LLWS7@^RF9 M<_'"W;^<56S%@VJP+!0ZP[,3*,J?;)+M)8LHVZ[Y` MOY4\N-$S<;4Y?+:J^*I:"=6&?<(=V!GS@-#[`D.PF)VMONMWX+LEA2SYOO$_ MS.&+5%7M8;L7X`B-9<7SK70"*@HT4;I`)F$:2`"N1"ML#:@(?^KO!U7X.J?I M,EHLXUD"<+*3SM\II*1$[)TW^D\`)4>J0)(>2>!^))E=3B5A(:'>WRWW?+.V MYD"@:4#2=1Q;,,F`^&U#X`2Q6P3G=$D)Y.I@%QXWJZLU>X3"B2/D)D#@.D"2 M`<%`G""$9AK"QFV00G%.X#LFO5@-M$`Z0^0BR&!`G M_@`RW1^"80?`U3_EUY4-F`G*T%'3E1'<*P^E#9%Y?Q[&&W;Y'EH$G]*&R&KD M,(GCMTL'#3;=`()/E4+DW``.X\FMCN!3VF,D#(IQ8<#3=%X$G_*&R'FZ,,]. M>''FS`#\GR.*JTX%>B((C4]+$K\^EF'VA=F@I:WD)]DTC@BSQ[F6PFD?HL/, MW:;8):_C\VP;9C$;OL`L['@EOW%;J=:11I;`&4=+Z#4;IFEX\::#1&$B&@]3 ML'^LX:\GX2E:?#Q M<,[Q>,;Q^MM[D1MOK*HS7FY,LEB:!BM3OL_*X\;\[]_GA]`TZB8I]TG.2[8Q M/UAM?MO^_MOZPJN7^L188T"$LMZ8IZ8YKRRK3D^L2.H%/[,21@Z\*I(&OE9' MJSY7+-G+245NVO!2L;#%*Q/&F`?WW*SG47 MK4CGA"N2ZN7U_)#RX@PA=EF>-1\RJ&D4Z>K[L>15LLM!]SMQD[2++;^,PA=9 M6O&:'YH%A+.0Z%CSH_5H0:3M>I^!`F&[4;'#QGPB*VH3T]JNI4$_,W:I!_\; M]8E?_JBR_5]9RQ`CO.7P3T^UX\@LG6:/:S7(&_*V//#LEKWOS#+W^R M['AJ8+D]4"2$K?8?E-4I.`IA%K8G(J4\!P+PUR@RD1K@2/(N/R_9OCEM3,=? M>,'2(0`W=JQNGC,1TC32U[KAQ2\$245]$+L-X@#[=AP>S9SLMI/ALYOL+US; M"\(9%"R4(]VA29-LUQ6_&)!R0+@^)R*!R0HB=[:@B-ZHKWP"@T20)Q%E8P:F M`1;4L+AO6]]?6V^P'FD+B<80HB+B#B',%U$I/H"_?51OV<^Q0$"O`EPX!"'#;I?.("K+FN$8L0`F_OM6G,XIL(.H50R/OWD!=@U?6!)S*= M(X1XZ#H)]5R.<=R5X^[RNN=P6PYG$V\PK'"&8C#?<`%6.?N/_3HB9X2TG%TW MT,9C99QX[BA3%(`?!@-7%.*BXP\JXG0M$6`U4P+-K@@A4YER$T&G$`KYQWO( M"[#J^H@\0H;D'4U??!M")R$*?P*-?;[[$JW9K]7EJ,4,)>@[]3:$3D)4!:)K MST3H_U1W>Z\JV_!$SN0`=1!S:'@*BE54J26U,[`7*N.J]Z&4#[\4Y MTH&]/%T]Q0%,LK.;F%Z'0,58!H<_,% M8%.$\M&?($.MM49DW#@U?O%M")V$*`KLN[JO1*L5*-3R-VHQDSDT`T.G,:J( MNQJP/6[`X;6_8!EM,=,B,,X41MQOB'+W!09%X`4&_D0O6'5D,;/%;5GL>D17\HH;G5C\`]QGGY,A^)-4Q*VLC9P<(N5P$4$$K MO!'!+PT_RXN!'6_@)D/^>X*;*P:_R9<+`!\X;[HOX@7]7=CV?P```/__`P!0 M2P,$%``&``@````A`+`"P1+V`@``X@@``!@```!X;"]W;W)K% M:/2)K4K&T%5,/>^;FT16#5#L1"G,FR6EI$JBI[R6BNU*T/T:S%ARXK8?`_I* M)$IJF1D/Z'P7Z%#SK7_K`]-FG0I0@&DGBF//E9!H` MG.RX-H\"*2E)]MK(ZH\#!38HQV5#>V"&;=9*'@C4&]"Z8=@]003$EV.!(!"[ M17!,EY2`&PT)?-FLIFO_!30G1\B]@\"SA00MP@>?K6-P-MXQ@M$Q)@4CN7>& MKIOPLIMIWPWF?/9NSD\Z\1!DMR-B-6OI70`.,NM`YBVBIQ,@XW4B&"H!ZMKT M#3+L,",\@\SQGA%L/;:1X\U_?@++==L>\D$5IN MO!0$]QTYRU`*;M;1S8_@/NW1XJ:^V]L@:3PO@ON\SC(,-X"5T^6U"R28>U=3 M;P_V?9Q,W1%:+2ZW<(!#/3I/%GWF#`E@\.PFZB8*._T_F(]3'_[;`Y8`G`UK M$)Q-_I7-YN89Z-K^MP07@SX;:5N&!:SB:Q,`E\MYJ4^F7AF69V5P-XI;VQ57 M.?_$RU*31.[QM@AA$;?6]B;;6B7G]EFT=3>&L::(\:^? M]S?/RWV7#S)DE*%@*&1,2Z5:B/;EFE):R(MWM(& M9G(N:J+@512V;`4E6;>HKFS/<:9V35B##4,DKN'@>I+QN@6++*J9>.U*,ZC1Z*!HNR+8"WR^N3]*>NWLY MHZ]9*KCDN;*`SC9"SSW/[;D-3,M%QL"!CAT)FL?XSHTV`;:7BRZ?WXSNY=$S MDB7??Q$L>V0-A;!AF_0&;#E_TM"'3`_!8OML]7VW`=\%RFA.=I7ZP?=?*2M* M!;L=@"'M*\I>$RI3"!1H+*^3D?(*!,`5U4Q7!@1"7KK[GF6JC/%D:@6A,W$! MCK94JGNF*3%*=U+Q^H\!N5K40.(=2":@_C`/0U>DZWL)^AFU-#YC5!X1.GA-FY@!N`ZT@3-> ML^DANH+`TN`+=N?8U^5BZ>5KL);??WAE!HX_?.)F?8X(W+&TY!QR0K*Y@`@' MDI$=J+OK[6@P5/E1;/-@H.V271D(%.1;LF/$^D-$\B%B\QYB9`^$7&]/@V,, MV0W:76EL:?&K+'^M>&8RQ=2YL;:8O"S,GZGT":.-:@^%W0VI#V,#K^&.T\?JY/QE1O!:==G=IB`EMV2@GXCHF"-1!7-@=*Q M0I`D3-,W+XJW7=?:<@7-NGLLX=],H5\X%H!SSE7_HC\P_.V7?P$``/__`P!0 M2P,$%``&``@````A`*A%;^(K`P``G0H``!@```!X;"]W;W)K\XR\<*6%+$+JC\:4\"*2L2CV(?WS^_%F M08DVK(A9)@L>TC>NZ=WF\Z?U4:IGG7)N"#`4.J2I,>7*\W24\ISID2QY`?\D M4N7,P*/:>[I4G,7VI3SS@O'XULN9**AC6*D^'#))1,0?9'3(>6$(9,Q"_ M3D6I3VQYU(1DEHF9@1TG@NTF_/26WK`M%G'`C+`LA/%DY!N_=6]OZ#>9FT+]%?PHV[\ M)CJ5QZ]*Q-]%P:':T"?LP$[*9X0^Q6B"E[W.VX^V`S\5B7G"#IGY)8_?N-BG M!MH]@XPPL57\]L!U!!4%FE$P0Z9(9A``?))3>0>"SAO@UP@.? MM6-PUM\Q@M$Q5A8CN7>&IIO@LIO)$#<(#BE\UL$OEC6M<^P@TP9D5B/.\@-( M__P0#!V`K-X]MROK,#T\PT3U]XQ@Z[DNK;-,K1Z:#;L=0HO@8FGI9?J!+!#7]7G&&Z)8S9[J0T2#)HQC:S)6IVP-_ MD,PMNA7T2==X"S2[Z[=T[$[^R6A^O0^UJ&MI6;)V'SXXN/!Z&=`'IUHHVKLS M9[K0AT%*]KM2/IDN]&&0=OVN>"O3A:!;\K5]"!9XW5[30U?+L"K8V3K3PZ1U M&KEEP%V6.5=[_H5GF2:1/.!%'\#U5UOK)61KZ]^V3U=;MYQX]3^P')1LSW\P MM1>%)AE/@'-LITJY]<(]&%G"O,"*(`VL!?9G"FL@ASMPC$=!(J4Y/>#HUHOE MYC\```#__P,`4$L#!!0`!@`(````(0!<6!18L@(``(L'```8````>&PO=V]R M:W-H965T&ULE%5;;YLP%'Z?M/]@^;T8R*V@D"I=U:W2*DW3 M+L^.,6`%8V0[3?OO=XP3!DVETA?`A\_?=VX^7M\\RQH]<6V$:C(<6`4-C,EQ9VZ:$&%9Q M24V@6M[`GT)I22TL=4E,JSG-NTVR)G$8+HFDHL&>(=53.%11",;O%#M(WEA/ MHGE-+?AO*M&:,YMD4^@DU?M#>\64;(%B)VIA7SI2C"1+'\I&:;JK(>[G:$[9 MF;M;7-!+P;0RJK`!T!'OZ&7,"4D(,&W6N8`(7-J1YD6&MU%Z&X68;-9=@OX( M?C2#;V0J=?RJ1?Y=-!RR#75R%=@IM7?0A]R98#.YV'W?5>"'1CDOZ*&V/]7Q M&Q=E9:'<"XC(!9;F+W?<,,@HT`3QPC$Q58,#\$12N-:`C-#G[GT4N:TR/)L' M\?4B6BP!CW;H"_". M6KI9:W5$T#4@:5KJ>C!*@?CMB"`4A]TZ<(97&(&O!LKPM$GF:_($F6,GR*V' MP+.'1#V"@&8O#&+3A1W8";O4.D]NO6$H$[\M,_N(C`-#;0;.)XN>U@M[R'P` M^8\8Q0>0Z?$Y,%0`HNK3=I%9CYF@#!TU7=F!.^4^M=XR[P[$L&#+C]`Z\)C6 M6Y)AA,L^MZ/,07]-]]^!QT+>V^?IUH]BTO^!4=C2DC]278K&H)H7P!D&*^@T[8>I7UC5@I\P M#Y6%&=A]5G#I<3CP80#@0BE[7H`RZ:_1S3\```#__P,`4$L#!!0`!@`(```` M(0#\,8]]%@(``*T$```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``!```` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````)Q446_:,!!^G[3_$.6])'35 M-"&3BB:A1:*!D<"T)\MS+L1JL"/;(.BOWX6($E:F:GL[WWW^_/GNL\G]?E,Y M.]!&*#ET^SW?=4!RE0NY'KK+;'SSS76,93)GE9(P=`]@W/O@\R>*@K!(5)\NP%IO5O?_^K!WH+, M(;^IWPC=EG&PL_]+FBO>Z#.K[%"CX(",ZKH2G%F\9?`LN%9&%=:)]QPJXG6+ M!-6EP+=:V$/@$Z^[)"EG%81('!2L,D"\T5R'ZUPUGQ4T2IN!9VF2-$;-)86^T4G MLIVV4%WE;W<(%0Y:&LCI`ZN8Y$#3=]?\$$Q1+L@/^%/++#0>,U05=(9&9?:? MMH3,E'1\?(DC2,ZGB2C))R,IC3-1EG\'"=9>G7+XVR2/-)PEH3Q(KF* M6,139(CH?+3(?EY%I,N'-/Z^Q#-HO/KK21<\-`++1$4S?&-;-&R7]\(7?SAA M*N2+6=:9BK"+)ZM?)DE:XAAR-,&I?DZ0)W2YKAJ2L&1R#?D)\[[0/,Q5^_L$ M_;N>_\5''W=RQ#O_,\%O````__\#`%!+`P04``8`"````"$`[PKG^S(!``!` M`@``$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````G)%=3\,@%(;O3?P/#?B)B.?HV=D.]B#7A"R"4V$(424>`],'D^_!-#U`2 M0P,&;`R8%A1_=R-X$_Z\T"^Q@=TR6Y=W]8H;XA-"+G)0YN5I0RLB$E3>O%3ZVAOM\!)I!X-_$(X#WWC__ MG'\!``#__P,`4$L!`BT`%``&``@````A`%28;%F'`0``60D``!,````````` M`````````````%M#;VYT96YT7U1Y<&5S72YX;6Q02P$"+0`4``8`"````"$` MM54P(_4```!,`@``"P````````````````#``P``7W)E;',O+G)E;'-02P$" M+0`4``8`"````"$`DAD1X4,!``"T!P``&@````````````````#F!@``>&PO M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`69!D7A8" M``!O!```#P````````````````!I"0``>&PO=V]R:V)O;VLN>&UL4$L!`BT` M%``&``@````A`&LM=+J8!```P1,``!@`````````````````K`L``'AL+W=O M&UL4$L!`BT`%``&``@````A`&3RZ$F(`@``*@<``!@````````` M````````-"0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT` M%``&``@````A`/MBI6V4!@``IQL``!,`````````````````62X``'AL+W1H M96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`;&&,8Z\"``",!P``&``` M```````````````>-0``>&PO=V]R:W-H965T&UL4$L!`BT` M%``&``@````A`%49LA+%!```4!,``!@``````````````````S@``'AL+W=O M&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`/PQCWT6`@``K00``!``````````````````FTD``&1O8U!R;W!S+V%P<"YX M;6Q02P$"+0`4``8`"````"$`[PKG^S(!``!``@``$0````````````````#G J3```9&]C4')O<',O8V]R92YX;6Q02P4&`````!,`$P#W!```4$\````` ` end XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2013
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 4 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the date of this filing and determined there are no events to disclose.

EXCEL 13 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W-V$P.39A9E\U.3,X7S1E93%?8C0X,U\Q8SEB M-S`R839F86(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E)%3$%4141?4$%25%D\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T* M("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!296=I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3QS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H M87)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)U$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO2!L;V%N'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-3`L,#`P+#`P,#QS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@Q+#0P,RD\#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG)FYB'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M6QE/3-$)V9O;G0Z M(#$S<'@O;F]R;6%L("=T:6UE#L@ M8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN M9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)V9O;G0Z(#$S M<'@O;F]R;6%L("=T:6UE#L@8V]L M;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N M=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M2!T;R!P2!T:&4@ M9FEN86YC:6%L('!O6QE/3-$)V9O;G0Z(#$S<'@O;F]R M;6%L("=T:6UE#L@8V]L;W(Z(",P M,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X M.R!L971T97(M#L@ M=VAI=&4M6QE M/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4MF4],T0R/D-E M28C.#(Q-SMS($1E8V5M8F5R(#,Q+"`R,#$R(&9I M;F%N8VEA;"!S=&%T96UE;G1S+B`F(S$V,#M4:&4@'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQP(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=F;VYT M.B`Q,W!X+VYO#L@;&5T=&5R+7-P86-I;F6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE"]N;W)M86P@)W1I;65S M(&YE=R!R;VUA;B<[(&UA"]N;W)M86P@)W1I;65S(&YE=R!R;VUA;B<[(&UA'0M:6YD M96YT.B`P<'@[(&QE='1E'0M3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0Z(#$S M<'@O;F]R;6%L("=T:6UE#L@8V]L M;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N M=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M'!E;G-E2!W:6QL(&)E('-U8V-E"]N;W)M86P@)W1I;65S(&YE=R!R;VUA;B<[ M(&UA'0M:6YD96YT.B`P<'@[(&QE='1E'0M"]N;W)M86P@ M)W1I;65S(&YE=R!R;VUA;B<[(&UA'0M:6YD96YT.B`P<'@[(&QE M='1E'0M3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@2!A9&IU2!I M9B!T:&4@0V]M<&%N>2!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"]N;W)M86P@)W1I;65S(&YE=R!R;VUA;B<[(&UA'0M:6YD96YT M.B`P<'@[(&QE='1E'0M3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A M;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)V9O;G0Z(#$S<'@O M;F]R;6%L("=T:6UE#L@8V]L;W(Z M(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@ M,'!X.R!L971T97(M#L@=VAI=&4M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQP(&%L:6=N/3-$ M:G5S=&EF>2!S='EL93TS1"=F;VYT.B`Q,W!X+VYO#L@;&5T=&5R+7-P86-I M;F#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T M97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\W-V$P.39A9E\U.3,X7S1E93%?8C0X,U\Q8SEB-S`R839F86(- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S=A,#DV869?-3DS.%\T M964Q7V(T.#-?,6,Y8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'1U86QS*2`H55-$("0I/&)R/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'1087)T7S XML 14 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY
6 Months Ended
Jun. 30, 2013
Related Party Transactions [Abstract]  
RELATED PARTY

NOTE 3 – RELATED PARTY

 

During the period ended June 30, 2013, the Company advanced additional $4,479 loan from related parties. The balance as of June 30, 2013 and December 31, 2012 was $6,185 and $1,706, respectively.  The advance from related parties is due on demand with no interest incurred.

XML 15 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Balance Sheets (USD $)
Jun. 30, 2013
Dec. 31, 2012
Current assets    
Cash      
Total current assets      
Total assets      
Current liabilities    
Accounts payable 1,500 3,351
Related party loans 6,185 1,706
Total current liabilities 7,685 5,057
Stockholders' (deficit)    
Common stock, no par value; 250,000,000 shares authorized; 54,521,000 issued and outstanding 81,781 81,781
Deficit accumulated during development stage (89,466) (86,838)
Total stockholders' (deficit) (7,685) (5,057)
Total liabilities and stockholders' (deficit)      
XML 16 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED FINANCIAL STATEMENTS
6 Months Ended
Jun. 30, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
CONDENSED FINANCIAL STATEMENTS

NOTE 1 – CONDENSED FINANCIAL STATEMENTS

 

The accompanying financial statements have been prepared by the Company without audit.  In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows June 30, 2013 and for all periods presented herein, have been made.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2012 financial statements.  The results of operations for the periods ended June 30, 2013 are not necessarily indicative of the operating results for the full year.

XML 17 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 18 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN
6 Months Ended
Jun. 30, 2013
Going Concern [Abstract]  
GOING CONCERN

NOTE 2 – GOING CONCERN

 

The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern

XML 19 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Balance Sheets (Parentheticals) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Statement of Financial Position [Abstract]    
Common stock, no par value (in dollars per share)      
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares issued 54,521,000 54,521,000
Common stock, shares outstanding 54,521,000 54,521,000
ZIP 20 0001078782-14-000332-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001078782-14-000332-xbrl.zip M4$L#!!0````(`"$P9T0F?P'U,TD M[8SU0KU9EL_NV)9T4>.3'=N7)M-V;B`2DI"C2`8`;2N=R6_O+DA*I$2]F93C MIDYFSC8![#Y8+AXL%B#Y[F]/$YL\,"&YZYP>&,7R`6&.Z5K<&9T>?+SO%IH' M?SO[\HMW?RH4R'OF,$$5LX@OH9QT?BW\>'%[%34G1\5RL5JLDG^6*R6C7JJ4 MC1HI-UOUXU:]2FX^_)L4"I&H"RI!#+31`BI%8UZFK[1=TY\P1Y$/`&7(H>XC M5V/4V+&X<@7Y(=0)B(N-8A-%_8-9#I,6G1Z2+AL(GXHI,8X/28"CTJJ56_4R MX`A5/0V$S5OX+P$;.++ER\'X]&"LE-&LZI+HQZJN:QP?'Y=TZ:RJ MY&D50:A1^O'#U9TY9A-:X(Y4U#$36/@:[(OUN71K%>-H78N@1M3`='U'B6FR MMY*9Q9'[4`H+M4$+9:-0-6;-?"'`\5:U"TNQ8279T&(\O0T4I.BQF">8B4Z\ MLDO')2I,X=JL-*2F*K`GSZ8.!:>;=N'O2!![,L?IBK$D13-W'IA4Z4V"LI1& M#N6F3&^CB[")L="$J35=T_V"*K/:KN/XD_0&EA(E-?6@ONL4H!83W)RUV]PH MV4"PX4I8C1*41A4E-],[#`4IW97*$ROJ0TE*`U\61I1ZLS9#*@<:2%B0DXJ><+UF%`Q)D3MF*J3Y!&>;82&',1Q6_'0N/UT//WVJ&H4V M,U&H<3!O`!,)5]/YW]S"*S"M"**[F^Q=Y#^7O>\.SLI`I_7:4;EBO"LM-D:! MI70-8`SN6C&-FE857-`."216->:MYZ71E7G[4J+/ZXU0_=`!$Y0+?_<=-$'E M59D`NBA4&Y@W,`+0>`T\?]X^7CX#;24:-`K5`N_2E?0/JY/T(CE%^M0181`%&7#=!NM5=E MMX0C`6,!>3_;D3">_NCPI6`:KW_Y1>\WXU_='VZ^94^L76\<-7^Z9;_PLP_" MEM-'WOL-RQJU>M.LU6IFO5XW[_\S/GM_?-1H-D\:QDD#_FDVNAVCT^F=&HUO MC[OOZ[739N/T)!&Q^Z@>S2_'5,`"Z2R\/F%4^H*=A1&71WR@C1>+' MN_:2N#`ET8*RW:5]`EM^ND,H,[D6?X"[>!:KW,?%+>8$GJEZJ3U>;#/'G7`G M3>RV!DJ(*"71+_0<;W_'9CK+%O>,=Q;CK8[VSULVXE()<+4^G3`2^M0MKMU6 M3V,?[PH75]^2B]YUH=-_W^MW.K>]_GO2Z]]_=DE0!/4 M[CD6>_J.3;?4'Q^!*V5%BNX%Q53GW70R<.TM%>"R-1"=:`TB\7\M]E+GJU27 M2Y/:/S$J.@%M;:FA$(1J@9)5LI*VZG*;B4NX/'+%MI:ZFU`;6I%;YKFP=G=& ML.R>>-29Q@V7$+QP?]S)Q'7NE&M^UN-%7OL*B0EMD@HAA70)NJ.N%%(#L9C) M`9@\/>CUNP=G]5J]8L`]3=S,-8HCB%$&^7[J;6MVP/5]H";>>%'@C:;:W6[H M?"9+RD_(BA2=0XF%I5V;IMMQ6<$0#,8"V8GFB^#G7M2%*W('^$G@"W+2U02] MVT71]Y4T-3$YJ"A,N+4NJ1R?.Q;^Z/SB\P=J0PMYKBZI$%/PA!^H[:??H)1D MT=P/<4*).6$9_*)9K37>E7;2FR_0V")['=!JO5S_77'&UL$+.)\D;SGN]'WM`I'=@LF]F33E^M M&W.G3]>3$SS`&QI@)T`M-D#LUT/0X([14<,PD`F/,$E:[,A-[F"P>9/?.U+;5_` MI+'8(A>;-9K59LR!,X,Z>[DN;GM7CFN-QKZZJ._NV+4M)B3.]"I]H;+C72DD M!_.RD@P0MK1:(3F:UT.(C76(>G*SR9JY-Y/&9\WVL='<=X'S]7+'TK$$_H_U)I]HL];_(9]K.V5!0=3;9C M7#`W:]7:LX!>>[B]!'P8EJ5G=#*,@24%NVO/XN8[H3=N7*'/RPL,(1YSJ>`V$G9RRL\L9L&';RR,(*E\S5#!L@K/#+;!`R M^&9AE7.F(^IA-H-)M2?V-N(QZX*N.(R^Z[A)H'L"5$@@6JDV:2(LN*=/8=D% M3$%#GD&AKQA0J\R+ZCD)L1>;6[[:D5B8+W3Q5-+[Z"L!N=Z?7PG(]=Z_!Y#_8'PTAFOG#T#<(];W)P,FKH>Z62P)DM%5EQ,Q MY;0TS//`)#=VT:'&\5']^/C5=FC-$/A#W*'?J4/`]H)1W,$*?O:< MA9WZ[/-Z;2&:6:_O+&]PFR;_9OS`Q`O`RQ(8UI]M2IC8\4C1C7#Q^*MU,?TH MF=5S9FN"C_C2;=EUQRSQ?F&.8HC>CW6F, M'!G'RW9!F,F0'L"A;L<@=NP0L$+XW*YHEO2S`OVZU=Z.Q5]RO3%LTV M<<6 MU\P2[DSNQT@[B\\;?6ZF`H$6[DE8X?"A]IV"*$-3^SUHNK"WG.>J!V=?V^K$ M(]3F(^?TX&=`R(?3`R+5%%^W,X1F+6)4O:>2XPH8%.0;Q2=,$H<]$IB.J?/- M"9E0,>).BY2]IQ-0:KNB1?XU<8T@FWIRVRT*]#_?<)6(+_RC!A&@D8X"_]Z_L., M_O;E%_]/-T+;S6B4_V\-D-43[\>,4-,,GI3%@X[#B`E`9$0%9$P?&!DPYA!/ M,(\*9I'!E"AH&SYCJU]HZ/J*4-_BJDCF-Z;GZ'JNQQU\)ML=@G$=.M*"#^$F MV81:>(\"17\!2YACPAW3]BUHY=C3T!Y$,'QO'D*,-?@K=,]D4N+;$96+Z"0^ MTC*D7-@!P'E_/%=R#`(.093T;=`&8-Q9:`!@'*!;F(_)T'8?)0%J8Z1:UJ]< MK.I"N-\:QC])()1;D#HP([H[TU M=$=7.:YBQ.+2M%U\?8(,D8'SAV/(@E_2!_5L*$,%I`!AX8(X>#4I#3+1.-H\ M&',F]VR0/0J.[(%P*&>>"MKB*,,W"M!%(IP2:0_&D&4"+74F"J4'03?8=/4C@P8C&BJL4#-GWTG>/V#[DB2`F*- MT(!H/(E5!`/RB!LL1FVSN?GH1!*(R!GNTI"JH7FADBH\WBTDV%2^T6R">B(V M80XJ7V`=P1#EC.6XOK$66!:/2J+`@%S#I.U,4R1[Z`-=31D5JZ@H?@Y]BU@P M^2`.K%N`[:?MF?N]Q8PO%3-6$C'C^VM\*0E$CI>=V_Y;B/@V_>0=(J9Q83JM M`F'-)I;@Q=HILT;Z]+)I+J&>9\-/W)@%NJ9DY(9/YIA,."2('#7O3#R;ALR. M,X/-?PTF39!%@S<"(/O;FK]F)?;\N<((27CW`:N0FFP'V",@XB*)&07F.*E) M>LH4@;D+`'(YQEZ"7"<`*4&$J46(X"D2G.F&^-`IAJO0&]-]@%F%XR0Q(W/3 ME2%4L)[["*5!39W6@K!=+MH@@!5T8QI-#A'*]4UQ[K68Q[1WXOO'XTW=`<8? M0>C-?O'UFV*HQQ78!J0.?4`X1PTS`1[4QMMK(^0!PX0&AAOND*-Q6)'TDM`X M5H_N:Z!L2=,AT0CF0'BQ;`0X,R?7# MYG!A$0S1EL.8!6O)"0Q]XF)L"57P0!QUXP"9CPSI`\_-&LY"O0C$(#Y>(SU#Z&ELX:U)18(?<*`@BF;",T?A8]0+ MS#1A0&M(3/B0#OK%?*BSZ*D,+8ZQS_IB\!0V7"H!,@LW28=1%SAPL$-&%H;TT!1_,UZ?XZ0>F M'TZ&:(N.!/7&>B!B@*%\'7!)S)FQD(8BP@#DLP$91!=*\\I\@HY/IV2[#*'E MZA`H2MSI01S+Z^E1/,'CCCATYSD[OB806&//C8O9=6O3^!HV?JKB'KV4ZMR! M?%O2OOR2MII8TMYVKL[O.VURL! M`Q(K'L5]53NL'1W#B@="-!UAB8!.D)!Q'1F0YX#:.K%*-?4N[RHLYQ0?H>I7 MC4.C6=<5OC(.C\H-O6WAX:MM'Y@]74PQAO!28>C9Q\?=%)A$)BA1IT8=3'D& MF_+(V_BF+FMSFG`'QDR\0<$?2(@,P4\Z#V^[RR])J[4$K=Y]O+CK?/^QT[\G MG1_>-I3?J'6/V4*=&&,/U/8U&\D9!00A*D:%PO5'09!K8:Y'!]4<4XMV%)Q: M#/H,2T^](P1D%6Z)S$2XT>[7RMW6V*O,5I'0\@$T_J$FR/2!4CQ^TW:^%PD\V=*,C#-$W&X+O;.C/ZD7'&_"+?HFO M[T%'=;@>?7]OZ8M^^&F(^2BS@*4EV;'OC."_\.=_`5!+`P04```` M"``A,&=$Q7L&R$H%```4-0``%0`<`'5S8F@M,C`Q,S`V,S!?8V%L+GAM;%54 M"0`#[J894^ZF&5-U>`L``00E#@``!#D!``#E6^MOVD@0_WY2_P[YG%__J!G`;.Y0-CVKW=[TS<^UKU_>_7'ZIVG^/!\-C2ZW M?0^8,BZ19D+!,994S8S>OV;/H8H+X\=&EH&BZI_JGPW\^CM+6W3^GDYO+9GX!&3,JD(L^^YM)@X MON;)R8D5O$522=LRX!]RFZC`69EZ&8D4^I>Y)3/U([-Y9+::]95T:MH'@KLP M@HD1+-]6ZSFE];&):_MN8/@05]_1"U8*D-/9:J:% M/7Z9`'EN[TAVM:^YV#4Y%!PX=$+D./"J+\TI(7-+N\("5\GMD\`Y9J,9.O=] M^/A71TI<]<(7`H-YNX!+QN`&R_Z*I[,*UO*"R%F'.?JC]X]/%\1%+61'71`A MUIBB/XCK0XKV^?BC"'?$KH%$V-LU\.L>O+NA'5)8TO>\0)I)%7A;_HG@7IJ# MM^ORI]AA<.&`P"J&1'E(RI2Q6%'/D<0URLMAW;YCX&[Q59D[$+.2I0/$.)\9+L\+W823"V M>D'4]>&&CP"]"9X$:F5TZ2EIB\"0[>:\G[QE8P:R&!;A\K@>6:T6FT&,*Q%Q0"5V8 M4)LJ+%"^YP<)T/4%[B2B'&G9_WSA;P+HEW!B=C4Q2]PVX-;R4<4ED[4:U3_5 MK"C*<5TC9T*_-5/C*'.V.RLR".,P$??W$O,[9@Y:K^><[Q,]^/1=OI2WC/@. M>L5YU$"?(>K5)OR,=0N>Q+Z!TDI<";Z@:,SY^A95'+#O$KP,=-$Z$'%$%4\/4#\! M1'?:S>>`14:J%/RR>0\0TQP.RU?J*U&;^I019K]";'K`9 MCJK@#/4P%@=2^OH^![=Z^>#-Y#T\A+/=%8+?>68(*9$[)]B;LP`\:PM;/6:=8)%`[8` M^1HSW<-'5 MZ*DG505J>5?N<^D:1UWJ."1(R5V_UA^I!0+!A_`4,]76SW'<>CC$JE MM5Y`J'4*-%F;=6R[PRS&^FK^KR*N]0[0\)4 M.,<6-:'9`;+/\5;`C;$UYXDJVA=S!'!Z]S\[^.,_4$L#!!0````(`"$P9T0) M5']/#!(``#GR```5`!P`=7-B:"TR,#$S,#8S,%]L86(N>&UL550)``/NIAE3 M[J894W5X"P`!!"4.```$.0$``-U=;6_;MA;^?H'['WBS#VL!IW'2-&VRM8,3 MVZVWU,Z-W6[#J%(21:9H1CBV3R'?,CGO)"B MR!]_>EI9X!&YV'3L]T>GK]I'`-DSQS#MQ?NC+Y/^\;NCGS[\^U\__N?X^+?K M^UO0=6;^"MD>^$S*S$UD@&^FMP2]OX][ANDY+O@:Z`)$U:N+5^\`^?@K,FR$ M#;AI@3Z:NCYT-^#TL@7.VJ?GH'UV==Z^>M,&=Y_!\3&MRC+M/Z<0(T":9N/W M1TO/6U^=G'S[]NW5T]2U7CGNXN2LW7Y]$A4\"DI>/6%SK_2WUU'9TY/?/M^. M9TNT@L>FC3UHSW925$V6W.GEY>4)^Y44Q>859O*WS@QZK+,*VP5R2]#_.XZ* M'=.OCD_/CE^?OGK"QA'M`]>QT#V:`U;]E;=9H_='V%RM+=IL]MW21?/L-EBN M>T+E3VRT@!XRJ/Y+JO_T@NK_+OSZ%DZ1=01HR2_W@UPXEWNZ`J&3#Z")%MXA MUW2,GEVNJ0GI1ML\]J#K56AU3+ZA=D\<#UJE6AR3;*BM0U2N;[=R3?4I<86H M7)_N)&MLJY=NIW1'[GJ0>FKZ^9;4O]PSEWG56E`8C:Y53JK!-AUH4P&42, M9J\6SN.)@7EZ> MO:7_+M]^[/?[/Y\_Y,HWP+R?S]J7IZ?GE_3?Z>7@TZ=/MQ?Y#4H3+N38KAR@ M!5602ZYK$YR2ZX8FJ'1#^.Q":T`<[-,O:%/DSO(%FW9?/`@Y[`D+`E82D*+* MG5/A.&0ZHZ)!.!1C)BZD\[CQ9C5U4N/#,XU]097N)@DAR93P=Q`4T,J_9/9^ MH6-)=WW\W^&X."%J9?S7GIQ*QY4`D+L: M0'_7RE-E]7RAB\KH]D,S8[NV+)HB90NJ\$!Y$'))$A34*S'BCD.N8^$-PJ$8 MTR$5&K32O@6S`E>N*>P+JO0F20A)IFQ_![2`5OXDL_<+'4I6UQ_:H^Q2]3[Y M!LOXE*2H2J^2AI'K5^*S+E98*\^2,QZ%OB5[,)IA3^#7\OA3&'332G3(8;*@ M%7$J#%G*6%6BJV63G;S!DF7:'.(IP^?CXP6$ZX!NR/)P]$V2=^'7#V./1$_: ME-&\;]K0GIFD/0XVY9ZV2>AJ_H&;%-`D*;=BP)F#K2"()/5ZYB8_I#F/W:3' MLSG"=C!&'N90,]-L M?`YQO3:70$VS/UP8EO7/V<*J''(>E&P3:(%HG5^=+52"$34?LO+:!`LNH;C1 M@<>FY@SB!N)EQS;HG]Y?OOD(+=(:W/%NH.MN3'OQ%5J^\/*?G%+5P4,4>HJ) M1`!`VP#L0TRT!:`'(FG`Q+4*-U4`UPYDG=HBVN3H>6"*%J9MTX$BB6G0F`-A MW&W=;18A(A3-Q:8\AY!R/$*IA8S7491QE,HT],@PBC.+VLW'B^W&KJ?%;).3J=(=W,"IA63G M*MG2RB8M>6!2B5Y8$(0E#S>/*;4L*@UC'934)CCQ6<6?U_`HU9Q=='TT<>Z1 MQ=Y(AF[,5&4##T>3ZL##!9G:8N`CX#D@+`["\@=<`8B].WQ`6!&>-2FX`98# M[?HG@%5BJ!28T&CH.+DQ7#J&TF(#$PJEA=:E,E@>U2R=<^E[DJHG? MTG@25P'O"P/-S9GIO=0N^HBOEY3MF_B+JXTFKN@16W"!>C9)I-:N MB5$W&`R28/LKGP7,KN^:]B(I(9W@5J]1M4W7TFFIA'E7!+`R8*>V!4+%(*89 M!*I!2K`^?Y!UEI4>?17T!HSUAA'TAA'K#9S5&\J=27TF)Y;RUF5O*A,#T=0X M0U+=+N@,$!4"O@89LQ"D(&/&8I&],@B!O4'EH5Q#BQY\V/QFG]J;K'"'?)XI M%^R'S[%C?1[V5GBBE*U/=58C`%CL(:]&.R)*8`K\EY5`)NC/E"<7HJR5??#$ MHVR#6Y!W9QP,'1(6\[8<9[JB;&%5Z4$>E-1SSKU#+(8L&U"S8;@.&#B`83MT MH1D\TL+@A6D#P[$LZ&*Z`Q5@>GJ%$LN2H(U($.,13HG-!.>"='QOZ;CFW[L# M1T5#&$^5ZNC%A\FWJO!HF)V$5BMJI9"%AH8#9#`7F?*`)4!/L2W=A=Q4:'(# MC/U,#R'[BD&>N*I<(A].DG)!2;`[%43# M\S\*!H<;@/DCT^##%F@A?(\>D>VC(9+?>I$05QUFTW#26_C8CRU`?M8JB`HW M73O7F\,AL4T1F01JCO\C$DBA1UQ[[VF-;(QX!]YD.H%\!:J<+`]2DE+;LB`J MK-L[6N70H+"P-K&BD&?<:%%$LN;LY2.R25.LCFUTC)5IL_L\//,1A0V3C1]% MZE3'DV*X20Z&$NRQT;Y,9&):19UJ`.&>C':!29"L0H%*C*D*`U?I@*5/H!(* M4!KLA!%I>/`@V7E&$:E<)%)'_&`*=>M@Z:,ELE2HCC39L/+-(9P@OZ`%ZU]> M*K_G0@P'_1I0@D86XJ3?I%(>/CA,$PH9^31KSEJ&CNWL-R,T7-EY3K$B56%$ M!&*2?W&9K2F%8B]UFP*5`3CRELB-@HXV,4>8C=P8)$K%)I=I/438X)6B-)ST\FQ00LLYC43S%1J(%"-DPDXVFS0(.95#C7XA1C:T:#!YD<$23F*> M5RRI%D,4/>*CR6&?`+YQ;-(DG[1JM$V,K]'<<5%0;@*?$.X]D3#GN(9I0WZCKG4()> M4Q?LA&X!)L6>0(=R6JS3RF/;X3"",LR6V'MPLW"3-%6D^TMR@ISEQE`1PJHX M(B=V-QN],*)O.=^D]XAQ=6AP3U\6,.[]?.SF$":AX[YIH M(^Y#=1WKMCES'O$=`*13X%:ECNEDC58H MFH?69X*-KL^X"-+SI8*_L1;'3Y20?Y-%1JO"U1PY\!DK(TP0O(A4O"0.)>9/ MXH>N:+9/H3+XFR7Y/_JBK1US"K&S6*ZT23'*D;QH$4F>X2K-.G'X>HF'304* M52M\\\29>SK>`?E_I4[[JD M/YIO^^KYI3XEK;!*ZE/.!)OS5Z2],X0,MH\W=I/=IHNFPL]2N#I4I2T%P%*7 M%X;%`Y+'[YG<`"K2[`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`4-9^Z` MKOZRZ;Z9<)J]JM`UZN)$13@FA%8M!HWEPW,Z-LUI#>S.R MK4W7Q#/+P;[+.VJZX$JWRC6JCBRU=%KZ_L10*=AJWKREAIR'%F>`G7!*!]2ZG8G6@R$Y?2,$P7C M4^#V^8/3G!>_-?_R39QG;``[9JSH_A^RXD+;4P?WU5X-:-0G^HIA0#@ M],6Q\>W1<2$]/;SF:@BJF%Q4,PBK!D'=].':..!KK/ZJ M-Q(H05Y@O=L.@&$'A&8:,T)V+T'PM9++".KIJZ395B%YT`FW1.T'\IG\F4*, MR`__!U!+`P04````"``A,&=$TA!V!@8+``!/G```%0`<`'5S8F@M,C`Q,S`V M,S!?<')E+GAM;%54"0`#[J894^ZF&5-U>`L``00E#@``!#D!``#M7=]SVS82 M?K^9^Q]XZFMEB7'BQIZX'?E7QE/']MA.VWOB0!0D84H1"D#*5O_Z6U"B1%($ M"5(487)N^I!$Q8+[[;?`+K`KZLMO;S/'6&#&"77/.^91OV-@UZ8CXD[..]]? M;KJ?.[_]^N]_??E/M_O7Q=.=<45M?X9=S_@&8\8$CXQ7XDV-ZW^ZUR/B46;\ ML9K+@*F.3HX^&_#7/_'(Q7R$EC\;-WC(?,26AGGZL_&A;WXT^A_./O;//O6- MQV]&MRL>Y1#W[R'BV`#57'[>F7K>_*S7>WU]/7H;,N>(LDGO0[]_W`L'=E8C MS]XXB8U^/0['FKV_OMT]VU,\0UWB<@^Y]E9*3),F9YZ>GO:"_PM#.3GC@?P= MM9$7&"M7+T,Z0ORK&P[KBH^ZYH?NL7GTQD<=80-&'?R$QT;P^#-O.H'7PV97A\WO'Y<`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`3PC3J2.M,49\&!C7Y]T)0O.56V#'X^$G2?]8?VQMRC$/XTV)YI%R MDGLWI"Y>^GJH/*H!YV!+!?WC`[5=%!4R9L+3I5"D-T4&X!MC.-2MB@,9^@?* M+S`;TNV%K`XFUT=094(3X[7=/R7YS<33'51/-IQI'NS M+K1)ZZL6E.>_)]55A]G"6:F#OOU&D-_+KC@Z%HH)EZKT-*\5_.HPVQ/J\X+C'M8ME MZKU.J_3(+45X,"?05+I-?+_Q_X7<:G.K>PH&+I!@;<U/*R#_;I9A-,NY7XSME83F4F_%3&\P5184WQ?+ MV8WA*F*:2\$5\QT'%I)^7#WI]>5">>].J-D%;UU0$6^44DB!)!(:LIYGY&#^ M!.=@U\?W.#-MBX_4G.G(+2@['>ZHWXJT9NW^[N3Z;2[6ADHGHE1&W$,0AMN7^^I2^/@UKZJ$&IS936W MNQ6F6070`<\8M6;U'@92O/Q0FQBIN8E-B:%T!M"*D2BU29N%J;ES;@]TL M2&T(N=O`:,_E:8YJS*:\1N*,KXOA>9L$H1U)WSUUA>A7PR%\LTZ24\$],)E-`-``MT`3?^[,A9@_C M`'2D8*+N">4FU-UG5]A!RL.4OR2GH86GE#=@Z^O#V2A3K/]F1TQ#!0I"BE#C MD=$%`4HNEM_!T+?NYCYI8'MDL>K@3\DH5>Y@*GG`^^GL22--'JZK@=Z.>X!2 M*9K>$%X=@RH)74NZZP$1PTCT?:_^C-@KVBVJ5*<5I0ATXUPZRXP M/V2>7/`![^?]'?OGR<6AMR/D[6>.@[F8[L)J94YR"">LL%C[_C:Y=1_TX3:Y M@@_07`2N=),K#KT=7QP`.]@8CX):9?Q7PH99#I0EIKE@6QW!Z0Z4`[T5"3Z< M5];WNU=$6-$=\<@W*K+\(E-0=[WVX*Z1B[X=WZN/+@'Q12KQE5S8A-4\)$]6 M=S6XSOU#:H"6!)?U>KBA[`G/?69/$5=WE%QAW87ENK:3;`OLWV?Z'K:4_6QY ML%17=VGZT"ZVOW7:T)"6_E[HU>\7)"]U,URMR#3ZWRU3YO!4%&%E/?#OSCFJ M?H^ZYA?05.D.*=`JVR3FN[]7W$IO:.+UL3*T_5M=8]X0^R$ MG-!.JK_T6V@&R]1[YUO.'PJ`JZQ_]EU\5^H1D:PFR>@PR]1\AUJ`(UG1.XZF M%?=?D>]FY)(9&VF9>B\_J^!S!]`!RWGU-:UN7B*S[5ZMNU-U5Y<(-0_CU>OL MX'0_1^[RP7665X3;#N4^4_F.[?Z3:WG;G)R=%V#ZPLF^(U*2U]RS6@DQLI1+ M$?_A-N6#+^"O%%)'P&ECYJHO6#%'X'3]D^/^VN6&4RLZ6>::DHS5L$3N".32 M(^)%_$)E962):5L0((X#Y&MZ;W:[H'-D550)``/NIAE3[J894W5X"P`! M!"4.```$.0$``.59;6_J-A3^/FG_P>-3)]T0Z-L*:GO5EU!5:FD']*[[=&42 M`]:"P[6=MNS7[]B)$P(F#:72-O$%F9SS/.?XL>/8QZ=?WZ8A>B%.SVM.@XYS4OI[__-/I+X[S?-F[0]>1'T\)D^@>?$:4!.B5R@GR M_G:\@,J(HV\)%P*J^G']!$'S#Q(P(@(\_X(Z9,ACS.>HV?J"]AO-0]38;Q\V MVD<-]'B/'$>%$OZ$3#&2F(^)[.(I$3/LD[/:1,I9VW5?7U_KL1A.ZGXT=8'B MH'%\H+(.B)C<&DT MW>?[N[[.SU"&E/U5\'X;\M#X'[C*/,2"&'=E#60&6'0^102-W4S*#^*F>3S8C<% M\>OCZ,5-C5IRI]%T#IH9+.8<9M\Z7&I5P/TB,"#4C@&#)4Y`9ISX[_0+_(D]L+)8(E/V0H2T0Q*;!<0P]84=HTT*TER" M1(S%4WOO`LE=.9_!H$7,`2_"J9_AW@<5`9R,UFIX[(+5.`KJV[L`!DL'A)SQ M-?Y@L0!BX8PQGF68$19#G4AJL.B:6APLY7H8&#D=QI*(!9A20E@QVK(82ZUH MF+%(8@G+XODIGLTH&T7JL7K/VFJ.#0"$5..I=VM?GO1,-&OO!0L\)JFLYN_CT(_#]0'<@K8?$?LJ8@%A0'B)0[5V]B>$2)'( MO,9F%W@?5.V#%B15.`.C%(T2^*Y+^XAA=9<3(BED4"KTDJ==]H.*LJ.](MVO M.S@.F4[B8?0P(UP'%4\,Q["G4U_UPEB\YVT?C\.UXY'SH6B$\:=6Z[%]VKVXL[U!]<#+Q[KSOH[X[:-Q&2)>X8E=O)-E\7K>'.A(#]BZ(;WDK_;*T_M(K:61>P_7?:]WY_@Y47>M]UZA1?GW#61 MF(8#\B;C;%M78K>*VVR4SE"TEY`@P_)__S:I'U4TZI$1TM68MCI6GM4$G`5EZ=``/T).(2L96Z M:VE!):G9WD6^YBD6;JQ`EX12F"=.3E5_$T&28:5$5LHM6V2BN39+I:S4NB:1 M58CZYQBJIE5R"CDOL'@YB4JNI9)K'G\HN6*I MNFHRBZA/RF`#*0QBB\CV@F^5!!:1W03X*7E\+(>/)&"_8*GX;AB`"GE4-5C9 M-4?9XF3#F3^;K4KOWYI4RF,1F/USZOO=-CRC;'PKR50=%FH(IUYG M-`Q0````(`"$P9T0`Q0````(`"$P9T3%>P;(2@4``!0U```5 M`!@```````$```"D@3(1``!U`L``00E#@``!#D!``!02P$"'@,4````"``A,&=$"51_3PP2```Y\@`` M%0`8```````!````I('+%@``=7-B:"TR,#$S,#8S,%]L86(N>&UL550%``/N MIAE3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`(3!G1-(0=@8&"P``3YP` M`!4`&````````0```*2!)BD``'5S8F@M,C`Q,S`V,S!?<')E+GAM;%54!0`# M[J894W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"$P9T1#?3FO?`4``.4@ M```1`!@```````$```"D@7LT``!U XML 21 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
6 Months Ended
Jun. 30, 2013
Feb. 10, 2014
Document And Entity Information [Abstract]    
Entity Registrant Name US-BLH BIO-ENGINEERING INT'L, INC.  
Entity Central Index Key 0001547021  
Trading Symbol usbh  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   54,521,000
Document Type 10-Q  
Document Period End Date Jun. 30, 2013  
Amendment Flag false  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q2  
XML 22 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statements of Operations (Unaudited) (USD $)
3 Months Ended 6 Months Ended 35 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Income Statement [Abstract]          
Revenue               
Operating expenses          
General and administrative 1,403 1,743 2,628 15,865 68,434
Total operating expenses 1,403 1,743 2,628 15,865 68,434
Loss from operations (1,403) (1,743) (2,628) (15,865) (68,434)
Other expense          
Interest expense         100
Total other expense         (100)
Income before taxes (1,403) (1,743) (2,628) (15,865) (68,534)
Income tax         (1,700)
Net loss $ (1,403) $ (1,743) $ (2,628) $ (15,865) $ (70,234)
Basic and diluted loss per common share (in dollars per share) $ 0.00 $ 0.00 $ 0.00 $ 0.00  
Weighted average shares outstanding (in shares) 54,521,000 54,521,000 54,521,000 54,697,599  
XML 23 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended 35 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Cash flows from operating activities      
Net loss $ (2,628) $ (15,865) $ (70,234)
Changes in operating liabilities:      
Accounts payable (1,851) 400 1,500
Net cash used in operating activities (4,479) (15,465) (68,734)
Cash flows from investing activities      
Cash flows from investing activities         
Cash flows from financing activities      
Proceeds from related party loans 4,479 1,343 6,185
Dividends paid     (19,232)
Proceeds from sale of stock     82,500
Cancellation of common shares   (719) (719)
Net cash provided by financing activities 4,479 624 68,734
Net change in cash   (14,841)  
Cash at beginning of period    18,346  
Cash at end of period    3,505   
Supplemental cash flow information      
Cash paid for interest         
Cash paid for income taxes         
XML 24 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY (Detail Textuals) (USD $)
6 Months Ended 35 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Dec. 31, 2012
Related Party Transactions [Abstract]        
Advance from related parties $ 4,479 $ 1,343 $ 6,185  
Payable to related parties $ 6,185   $ 6,185 $ 1,706
XML 25 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 10 51 1 false 0 0 false 3 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.usbh.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Condensed Balance Sheets Sheet http://www.usbh.com/role/CondensedBalanceSheets Condensed Balance Sheets false false R3.htm 003 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://www.usbh.com/role/CondensedBalanceSheetsParentheticals Condensed Balance Sheets (Parentheticals) false false R4.htm 004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://www.usbh.com/role/CondensedStatementsOfOperationsUnaudited Condensed Statements of Operations (Unaudited) false false R5.htm 005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://www.usbh.com/role/CondensedStatementsOfCashFlowsUnaudited Condensed Statements of Cash Flows (Unaudited) false false R6.htm 006 - Disclosure - CONDENSED FINANCIAL STATEMENTS Sheet http://www.usbh.com/role/CondensedFinancialStatements CONDENSED FINANCIAL STATEMENTS false false R7.htm 007 - Disclosure - GOING CONCERN Sheet http://www.usbh.com/role/GoingConcern GOING CONCERN false false R8.htm 008 - Disclosure - RELATED PARTY Sheet http://www.usbh.com/role/RelatedParty RELATED PARTY false false R9.htm 009 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.usbh.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R10.htm 010 - Disclosure - RELATED PARTY (Detail Textuals) Sheet http://www.usbh.com/role/RelatedPartyDetailTextuals RELATED PARTY (Detail Textuals) false false All Reports Book All Reports Process Flow-Through: 002 - Statement - Condensed Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 003 - Statement - Condensed Balance Sheets (Parentheticals) Process Flow-Through: 004 - Statement - Condensed Statements of Operations (Unaudited) Process Flow-Through: 005 - Statement - Condensed Statements of Cash Flows (Unaudited) usbh-20130630.xml usbh-20130630.xsd usbh-20130630_cal.xml usbh-20130630_lab.xml usbh-20130630_pre.xml true true